Urologic Oncology: Seminars and Original Investigations

Title Publication Date Language Citations
Nanoparticles for drug delivery in cancer treatment2008/01/01English448
Micro-RNA profiling in kidney and bladder cancers2007/09/01English432
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer2010/11/01English400
New frontiers in nanotechnology for cancer treatment2008/01/01English191
Incidence trends in primary malignant penile cancer2007/09/01English175
Molecular pathways of urothelial development and bladder tumorigenesis2010/07/01English171
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer2015/02/01English164
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆2006/07/01English163
The impact of variant histology on the outcome of bladder cancer treated with curative intent2009/01/01English156
Clinical application of a 3D ultrasound-guided prostate biopsy system2011/05/01English154
Mechanisms mediating androgen receptor reactivation after castration2009/01/01English152
Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study2015/01/01English149
UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing2008/11/01English145
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression2010/07/01English139
The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor2013/10/01English131
Bladder cancer in the elderly2009/11/01English131
Chronic inflammation and bladder cancer2007/05/01English131
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results2018/10/01English123
The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research2014/04/01English122
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer2013/07/01English120
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium2010/07/01English116
The “male lumpectomy”: Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up2008/09/01English109
Natural history of untreated renal cell carcinoma with venous tumor thrombus2013/10/01English108
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital2013/11/01English105
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance2015/05/01English105
Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance2011/03/01English104
Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression2011/01/01English102
Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases2016/09/01English102
Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy2008/09/01English101
Statistical consideration for clinical biomarker research in bladder cancer2010/07/01English101